tiprankstipranks
Cynata Therapeutics Reports Options Expiry
Company Announcements

Cynata Therapeutics Reports Options Expiry

Cynata Therapeutics Limited (AU:CYP) has released an update.

Cynata Therapeutics Limited has announced the cessation of 300,000 options due to their expiry without being exercised or converted. The announcement, dated May 17, 2024, indicates that these securities ceased on May 16, 2024. This update provides investors with important information regarding changes in the company’s issued capital.

For further insights into AU:CYP stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskCynata Spotlights Cymerus Platform at Biotech Summit
TipRanks Australian Auto-Generated NewsdeskCynata Therapeutics Plans New Share Issue
TipRanks Australian Auto-Generated NewsdeskCynata Therapeutics Acquires Innovative Wound Tech
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!